ANDA 200122, held by Areva Pharms. Terbutaline Sulfate.
As of Nov 16, 2026, ANDA 200122 (Terbutaline Sulfate), held by Areva Pharms, was first approved by FDA on Nov 8, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 8, 2013 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Terbutaline Sulfate1MG/ML ยท injectable;injection | Terbutaline Sulfate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters